Advertisement
Advertisement
U.S. Markets close in 46 mins
Advertisement
Advertisement
Advertisement
Advertisement

Nanophase Technologies Corporation (NANX)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.2500-0.0800 (-2.40%)
As of 03:52PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.3300
Open3.3100
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range3.0000 - 3.4400
52 Week Range1.4100 - 4.4500
Volume35,358
Avg. Volume25,065
Market Cap158.358M
Beta (5Y Monthly)1.27
PE Ratio (TTM)47.10
EPS (TTM)0.0690
Earnings DateMar 09, 2022 - Mar 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.50
  • GlobeNewswire

    Nanophase Reports Record Revenue for First Quarter as it Sets Stage for Strong Year

    — Delivered a record $8.2 million in Q1 revenue — In Beauty Science markets, Solésence revenue is up 29% YOY while Active Pharmaceutical Ingredients (API) sales are up 70% — Added key team members to support growth ROMEOVILLE, Ill., May 11, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors

  • GlobeNewswire

    Nanophase Technologies Announces First Quarter 2022 Financial Release and Conference Call Details

    Romeoville, IL., May 04, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced the Company will disseminate a financial news release for the First Quarter 2022 after market close on Wednesday, May 11, 2022, with an investor conference call to fol

  • GlobeNewswire

    Set Up For Strong Growth, Nanophase Reports Second Consecutive Year of Record Financial Results for 2021 as Solésence Continues to Lead and Personal Care Ingredients Category Thrives

    — Another record year with 70% YOY growth — Delivered $29 Million in full year revenue — In Beauty Science markets, Solésence revenue is up 170% YOY while Active Pharmaceutical Ingredients (API) sales are up 40% — Acquired new facility space to support strategic growth and improve operational effectiveness — Closed on January 2022 financing to double borrowing capacity ROMEOVILLE, Ill., March 31, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-base

Advertisement
Advertisement